Login / Signup

Low-dose IL-2 may enhance the effect of vedolizumab.

Cheng Hiang LeeSarah HuangPeter HsuRupert W L LeongBrigitte NananRalph Nanan
Published in: Scandinavian journal of gastroenterology (2022)
Keyphrases
  • low dose
  • ulcerative colitis
  • patients with inflammatory bowel disease
  • high dose